Emerging Role of Baricitinib in Dermatology Practice: All We Need to Know!

Baricitinib is a competitive inhibitor of the Janus Kinase family of non-receptor protein kinases, predominantly acting against JAK-1 and JAK-2 subtypes. By downregulating transcription of various pro-inflammatory cytokines, this drug has shown efficacy across various dermatoses. Approved for severe...

Descripción completa

Detalles Bibliográficos
Autores principales: Dogra, Sunil, Shah, Shikha, Sharma, Ayush, Chhabra, Seema, Narang, Tarun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2023
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10115327/
https://www.ncbi.nlm.nih.gov/pubmed/37089829
http://dx.doi.org/10.4103/idoj.idoj_542_22

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10115327/
https://www.ncbi.nlm.nih.gov/pubmed/37089829
http://dx.doi.org/10.4103/idoj.idoj_542_22

Ejemplares similares